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Golgi localized b1-adrenergic receptors
stimulate Golgi PI4P hydrolysis by PLCe
to regulate cardiac hypertrophy
Craig A Nash1†, Wenhui Wei1†, Roshanak Irannejad2, Alan V Smrcka1*
1Department of Pharmacology, University of Michigan School of Medicine, Ann
Arbor, United States; 2Cardiovascular Research Institute, University of California,
San Francisco, San Francisco, United States
Abstract Increased adrenergic tone resulting from cardiovascular stress leads to development
of heart failure, in part, through chronic stimulation of b1 adrenergic receptors (bARs) on cardiac
myocytes. Blocking these receptors is part of the basis for b-blocker therapy for heart failure.
Recent data demonstrate that G protein-coupled receptors (GPCRs), including bARs, are activated
intracellularly, although the biological significance is unclear. Here we investigated the functional
role of Golgi bARs in rat cardiac myocytes and found they activate Golgi localized,
prohypertrophic, phosphoinositide hydrolysis, that is not accessed by cell surface bAR stimulation.
This pathway is accessed by the physiological neurotransmitter norepinephrine (NE) via an Oct3
organic cation transporter. Blockade of Oct3 or specific blockade of Golgi resident b1ARs prevents
NE dependent cardiac myocyte hypertrophy. This clearly defines a pathway activated by internal
GPCRs in a biologically relevant cell type and has implications for development of more efficacious
b-blocker therapies.
DOI: https://doi.org/10.7554/eLife.48167.001
Introduction
Cardiovascular diseases, including heart failure, are the leading cause of disease and death in the
developed world. In response to long term pathological stress, such as hypertension or myocardial
infarction, the levels of neurohumoral factors such as epinephrine, endothelin and angiotensin II
increase. These hormones directly stimulate G protein-coupled receptors (GPCRs), including b-
adrenergic receptors in cardiac myocytes (D’Angelo et al., 1997; Adams et al., 1998;
Rockman et al., 2002). Chronic stimulation of these receptors, including stimulation of b-adrenergic
receptors (bARs) by catecholamines, drives cardiac hypertrophy and ventricular remodeling, ulti-
mately leading to heart failure. The efficacy of b-blocker therapy for treatment of heart failure
results, at least in part, by ameliorating chronic bAR stimulation in the heart (Bristow, 2000;
Wang et al., 2018).
Previous studies by our group, and others, have implicated specific phospholipase C (PLC)
enzymes downstream of Gq and Gs-coupled GPCRs in the regulation of cardiac hypertrophy. PLCb
isoforms stimulated by Gq have been implicated in cardiac hypertrophy driven by cell surface a-
adrenergic receptors (aAR) (Filtz et al., 2009; Grubb et al., 2011). Our laboratory identified a criti-
cal role of PLCe in cardiac hypertrophy driven downstream of the endothelin (ET-1A) receptor and
cAMP signaling by bARs (Zhang et al., 2011; Zhang et al., 2013). PLCe is poised as a nexus for mul-
tiple receptor signaling systems due to its diversity of upstream regulators including heterotrimeric
G protein bg subunits and small GTPases, including Rap, Rho and Ras, and cAMP via the Rap gua-
nine nucleotide exchange factor (GEF), Epac (Kelley et al., 2004; Malik et al., 2015; Kelley et al.,
2001; Harden and Sondek, 2006; Smrcka et al., 2012).
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PLCe and Epac are scaffolded together at the nuclear envelope in cardiac myocytes by the hyper-
trophic organizer, muscle-specific A kinase anchoring protein (mAKAPb), in close proximity to the
Golgi apparatus (Dodge-Kafka et al., 2005). Activation of PLCe in cardiac myocytes induces hydro-
lysis of phosphatidylinositol-4-phosphate (PI4P) at the Golgi apparatus leading to release of diacyl-
glycerol (DAG) and inactive IP2 in the vicinity of the nucleus to facilitate nuclear protein kinase D
(PKD) and subsequent downstream hypertrophic pathways (Zhang et al., 2013; Vega et al., 2004).
In previous work we found that either the Epac-selective cAMP analog, cpTOME, or forskolin stimu-
lation of adenylate cyclase, activate PLCe-dependent Golgi PI4P hydrolysis in cardiac myocytes. Sur-
prisingly, the bAR agonist isoproterenol (Iso), does not stimulate Golgi PI4P hydrolysis despite
strongly stimulating cAMP production (Nash et al., 2018). As an explanation for this apparent para-
dox we demonstrated PLCe-dependent PI4P hydrolysis can be controlled by two distinct pools of
cAMP delimited by distinct PDE isoforms. One pool, limited by PDE3 acts through Epac and Rap1
to activate PLCe, while a second pool controlled by PDE2 and/or PDE9A inhibits PLCe activity
through activation of PKA (Nash et al., 2018). cAMP generated downstream of Iso cannot access
the Epac/mAKAPb/PLCe complex unless PDE3 is specifically inhibited, partially explaining the lack of
activation of Golgi PI4P hydrolysis by Iso.
A new paradigm for generating localized cAMP signals in cells has been established by a number
of recent studies indicating that GPCRs in different intracellular compartments have discrete signal-
ing outputs (Vilardaga et al., 2014; Irannejad et al., 2017; Irannejad et al., 2013; Irannejad and
von Zastrow, 2014; Stoeber et al., 2018; Calebiro et al., 2009). An emergent idea is that bARs
internalized into endosomes continue to stimulate cAMP accumulation resulting in cellular outcomes
distinct from those generated by bARs at the cell surface. Irannejad et al. (2017) established that
b1ARs expressed at the Golgi apparatus in HeLa cells can induce G protein activation in the Golgi
when stimulated by either a cell permeant agonist, dobutamine, through passive diffusion, or the
physiological hormone epinephrine, when transported across the cell membrane by the organic cat-
ion transporter, Oct3. These ideas led us to hypothesize that in cardiac myocytes, bARs resident at
the Golgi apparatus could generate cAMP that has privileged access to the Epac/mAKAPb/PLCe
scaffold at the nuclear envelope/Golgi interface, thereby yielding a set of signals divergent from
those generated by cell surface bARs. We demonstrate that endogenous b1ARs at the Golgi appara-
tus in cardiac myocytes are required to stimulate hypertrophic Epac/PLCe-dependent PI4P hydrolysis
at the Golgi, and that these intracellular bARs can be accessed by physiological neurotransmitters,
and synthetic b-blockers and agonists. These data present a potential new paradigm for drug devel-
opment for treating heart failure through deliberate targeting of internal bARs in cardiac myocytes.
Results
Dobutamine induces b1-AR activation and PI4P hydrolysis at the Golgi
In previous studies we showed that cAMP produced upon stimulation with the bAR agonist, Iso,
does not induce PI4P hydrolysis at the Golgi in NRVMs without addition of a PDE3 inhibitor
(Nash et al., 2018). We hypothesized that intracellular bARs may be required to generate a specific
pool of cAMP with privileged access to the Epac/mAKAPb/PLCe complex, and that the cell imper-
meant agonist, Iso, is unable to access these internal receptors. To test this hypothesis, we utilized
the membrane permeant b1AR-agonist, dobutamine, either alone, or in combination with the bAR
antagonists, metoprolol and sotalol, which are membrane-permeant and -impermeant, respectively
(Irannejad et al., 2017). NRVMs were transduced with an adenovirus expressing the PI4P biosensor,
FAPP-PH-GFP and stimulated with dobutamine (100 nM) or PBS. In contrast to Iso, dobutamine stim-
ulated rapid and sustained PI4P hydrolysis (Figure 1A, left). Addition of metoprolol, but not sotalol,
blocked dobutamine-stimulated PI4P hydrolysis (Figure 1A middle and right panels). This indicates
that stimulation of an intracellular population bARs is required for dobutamine-mediated PI4P hydro-
lysis. To visualize bAR activation at the Golgi apparatus, NRVMs were transfected with translocatable
Venus-based sensor of Gs coupled receptor activation, NES-Venus-mini-Gs (Wan et al., 2018).
When a Gs coupled receptor is activated, NES-Venus-mini-Gs binds to the activated receptor, which
is then visualized as translocation from the cytoplasm to membranes where the activated receptor is
located, providing information on receptor activation in subcellular compartments. In unstimulated
cells NES-Venus-mini-Gs is distributed throughout the cytoplasm. We did not detect translocation of
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Figure 1. Dobutamine induces PI4P hydrolysis through the activation of internal bARs. (A) NRVMs were transduced with FAPP-PH-GFP and stimulated
as indicated. Time lapse live cell microscopy was used to quantitate Golgi associated FAPP-PH-GFP fluorescence was quantitated as previously
described (Zhang et al., 2013; Malik et al., 2015). NRVMs were stimulated with dobutamine alone (100 nM, left) (N = 9), dobutamine in the presence
or absence of metoprolol (100 mM, center) (N = 4), or dobutamine in the presence or absence of sotalol (5 mM, right) (N = 8). Data are not significantly
Figure 1 continued on next page
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NES-Venus-mini-Gs to endogenously expressed receptors (data not shown), although, as has been
previously reported, we were able to detect staining of endogenous b1ARs at the Golgi in cardiac
myocytes (Figure 1—figure supplement 1), so NRVMs were cotransfected with FLAG-b1AR. Addi-
tion of dobutamine to cells co-expressing NES-Venus-mini-Gs and FLAG-b1AR, caused a rapid clear-
ance of cytoplasmic fluorescence and accumulated fluorescence at the PM and punctate structures,
possibly corresponding to microtubules. This was followed by slower translocation of Venus associ-
ated fluorescence to the perinuclear region of the cell colocalizing with the CFP-giantin, a marker for
the Golgi apparatus (Figure 1B,D and E and Figure 1—video 1). Iso also caused rapid translocation
to the PM but, in contrast to dobutamine, no accumulation at the perinuclear region was observed
(Figure 1C,D and E and Figure 1—video 2). To further confirm association of NES-Venus-mini-Gs
with the Golgi, cells were treated with dobutamine for 8 min to cause NES-Venus-mini-Gs transloca-
tion to the perinuclear region, followed by treatment with Brefeldin A. Brefeldin A treatment signifi-
cantly reversed NES-Venus-mini-Gs association with the perinuclear region, confirming Golgi
localization of NES-Venus-mini-Gs (Figure 1—figure supplement 2 and Figure 1—video 3). Taken
together, these data support the idea that a population of bARs present at the Golgi can be acti-
vated by exogenous agonists and stimulate Gs, ultimately resulting in PLC activation and PI4P
hydrolysis.
PI4P hydrolysis by Dobutamine requires Golgi-localized PLCe and Epac
Previous data from our laboratory demonstrated that the Epac/mAKAPb/PLCe complex is responsi-
ble for cAMP-mediated PI4P hydrolysis at the Golgi in NRVMs (Zhang et al., 2013; Nash et al.,
2018). To determine if this complex is responsible for dobutamine stimulated PI4P hydrolysis we uti-
lized adenoviral shRNA to deplete PLCe, or adenoviral transduction of the RA1 domain of PLCe,
which competes for the interaction between PLCe and mAKAPb, disrupting the mAKAPb-PLCe com-
plex (Zhang et al., 2011). PLCe (PLCE1) shRNA depletion of PLCe completely inhibited PI4P hydroly-
sis stimulated by dobutamine, while negative control (NC) scrambled shRNA had no effect
(Figure 2A). Viral expression of the PLCe RA1 domain also inhibited PI4P hydrolysis stimulated by
dobutamine (Figure 2B). This demonstrates that mAKAPb- scaffolded PLCe is required for
Figure 1 continued
different between dobutamine and dobutamine + sotalol. Data are from at least 4 cells for each N. (B) NRVMs were transfected with b1-ARs and NES-
Venus-mini-Gs, followed by viral transduction with CFP-Giantin. Representative confocal fluorescence images of dobutamine-mediated NES-Venus-
mini-Gs recruitment (100 nM, B left), CFP-Giantin Golgi marker (B, center) and histogram of representative NES-Venus-mini-Gs recruitment (B, right).
Red arrow = Perinuclear region, Black arrow = sarcolemma. The yellow line indicates where histogram data was captured. Scale bars are 10 mm. (C)
Representative confocal fluorescence images of Iso-mediated NES-Venus-mini-Gs recruitment (100 nM, left), CFP-Giantin Golgi marker (B, center) and
histogram of representative NES-Venus-mini-Gs recruitment. Yellow line indicates where histogram data was captured. Scale bars = 10 mm (D) Mean
data of fluorescence intensity of NES-Venus-mini-Gs at the perinuclear region corresponding to the Golgi ± SEM from at least 5 cells. (E) Pearson’s
correlation coefficient for overlap of YFP-Mini-Gs and CFP-Giantin images. All symbols on time course graphs are presented as mean ± standard error
from N = 4 or more independent preparations of myocytes. Agonists were added where indicated by the arrow.
DOI: https://doi.org/10.7554/eLife.48167.002
The following video, source data, and figure supplements are available for figure 1:
Source data 1. PI4P hydrolysis is stimulated by dobutamine and inhibited by a cell permeable antagonist.
DOI: https://doi.org/10.7554/eLife.48167.005
Source data 2. Dobutamine but not Iso stimulates Mini Gs translocation.
DOI: https://doi.org/10.7554/eLife.48167.006
Figure supplement 1. Staining of endogenous b1AR in cardiac myocytes.
DOI: https://doi.org/10.7554/eLife.48167.003
Figure supplement 2. Disruption of the Golgi apparatus reverses mini-Gs protein recruitment to the perinuclear region by dobutamine.
DOI: https://doi.org/10.7554/eLife.48167.004
Figure 1—video 1. Dobutamine activates b1ARs in the Golgi apparatus.
DOI: https://doi.org/10.7554/eLife.48167.007
Figure 1—video 2. Isoproterenol does not activate b1ARs in the Golgi apparatus.
DOI: https://doi.org/10.7554/eLife.48167.008
Figure 1—video 3. Disruption of the Golgi apparatus inhibits activation of b1ARs in the Golgi apparatus.
DOI: https://doi.org/10.7554/eLife.48167.009
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dobutamine-mediated PI4P hydrolysis. The Epac-selective inhibitor HJC0726 inhibited (Zhu et al.,
2015) PI4P hydrolysis stimulated by dobutamine (Figure 2C), however, the bg inhibitor Gallein had
no effect (Figure 2D). Taken together, these data indicate that Golgi PI4P hydrolysis stimulated by
intracellular GPCRs requires the Epac/mAKAPb/PLCe complex.
Inhibition of Golgi bARs prevents PI4P hydrolysis stimulated by
dobutamine
The data presented so far suggest that dobutamine acts through bARs at the Golgi apparatus to
stimulate Golgi PI4P hydrolysis. To more directly demonstrate a requirement for endogenous bAR
activation in the Golgi we targeted the bAR selective nanobody, Nb80, to the Golgi apparatus using
the rapamycin inducible FRB-FKBP system. This approach has been previously used to inhibit bARs
at the Golgi in Hela cells (Irannejad et al., 2017). NRVMs were transduced with virus containing
CFP-Nb80-FRB and FKBP-mApple-GalT protein for Golgi targeting, along with a virus expressing
GFP-FAPP-PH. Cells were selected that were positive for mApple, CFP and GFP fluorescence. Upon
addition of rapamycin, translocation of CFP-Nb80-FRB to the Golgi apparatus was observed
(Figure 3A). In cells pretreated with vehicle control, dobutamine stimulated PI4P hydrolysis. How-
ever, following addition of 1 mM Rapamycin, dobutamine-induced PI4P hydrolysis was significantly
inhibited (Figure 3B). These data confirm that bARs expressed directly on the Golgi are required for
dobutamine-mediated PI4P hydrolysis at the Golgi.
Nb80 can bind to and block both b1 and b2ARs, and while dobutamine is relatively selective for
b1ARs over b2ARs, it can still potentially stimulate b2ARs. To confirm that dobutamine stimulated
PI4P hydrolysis is through b1ARs, cells were treated with the cell permeant, highly selective, b1AR
antagonist CGP-20172 (100 nM) followed by stimulation with dobutamine. CGP-20172 completely
blocked dobutamine-stimulated PI4P hydrolysis (Figure 3C), indicating that the dobutamine stimula-
tion of Golgi localized PI4P hydrolysis is through Golgi localized b1ARs.
Norepinephrine (NE) induces PI4P hydrolysis and bAR activation at
internal membranes in cardiac myocytes
Thus far we have shown that the synthetic b1AR selective agonist, dobutamine, can enter cells, acti-
vate intracellular bARs, and stimulate intracellular PLC activity which has interesting pharmacological
implications but may not be relevant to physiological cardiac regulation. For this reason, we deter-
mined if the sympathetic neurotransmitter norepinephrine (NE) could stimulate PI4P hydrolysis and
bAR activation at the Golgi in NRVMs. Cells transduced with adenovirus containing FAPP-PH-GFP
were stimulated with NE (10 mM) at 37˚C. NE caused delayed, but robust PI4P hydrolysis (Figure 4A,
left). PI4P hydrolysis initiated by NE was blocked by metoprolol (100 mM, Figure 4A, center) but not
sotalol (5 mM, Figure 4A, right) indicating that NE can stimulate internal bARs. To further determine
if NE could enter cells and activate bARs at the Golgi, we monitored NES-Venus-mini-Gs recruitment
to the Golgi in response to NE. NE initially stimulated NES-Venus-mini-Gs translocation to the
plasma membrane as was observed for dobutamine, followed by slower, NES-Venus-mini-Gs translo-
cation to the Golgi (Figure 4B and Figure 4—video 1). Since PM and Golgi recruitment are difficult
to see in the same confocal plane for Figure 4—video 2 a separate cell was imaged in a confocal
plane that emphasizes Golgi recruitment of Venus-mini-Gs. Thus, NE enters cardiac myocytes,
accesses internal bARs, and stimulates PI4P hydrolysis.
Inhibition of the membrane cation transporter, OCT3, prevents
norepinephrine induced PI4P hydrolysis
Data from other laboratories has demonstrated that transport of norepinephrine or epinephrine into
cells by organic cation transporter family of proteins (OCT proteins) is required for activation of
internal receptors in adult cardiac myocytes (Wright et al., 2008) and HELA cells (Irannejad et al.,
2017). The non-selective cation transporter, OCT3 has been shown to be responsible for this trans-
port, therefore we utilized three structurally distinct inhibitors of OCT3, corticosterone (100 mM,
Figure 5A), abacavir (10 mM, Figure 5B) and lamotrigine (10 mM, Figure 5C) (Dickens et al., 2018)
to determine if OCT3 is required for NE-stimulated intracellular PI4P hydrolysis. Preincubation of
NRVMs with any of these inhibitors prevented NE from inducing PI4P hydrolysis, suggesting that
OCT3-mediated transport is required for stimulation of PI4P hydrolysisby this catecholamine. In
Nash et al. eLife 2019;8:e48167. DOI: https://doi.org/10.7554/eLife.48167 5 of 22
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Figure 2. Dobutamine-mediated PI4P hydrolysis requires Epac and mAKAPb bound PLCe. NRVMs were transduced with FAPP-PH-GFP, stimulated with
treatments as indicated and Golgi associate fluorescence was monitored with time. (A) PLCe knockdown prevents dobutamine-mediated PI4P
hydrolysis. NRVMs were transduced for 48 hr with adenovirus expressing shRNA for PLCe or scrambled control shRNA before stimulation with 100 nM
dobutamine (at arrow) (N = 3 independent experiments). (B) Disruption of PLCe-mAKAPb interaction prevents PI4P hydrolysis stimulated by
dobutamine. NRVMs were transduced with RA1 domain expressing adenovirus or control virus (NC-negative control) as previously described 24 hr
before experimentation. Cells were stimulated with 100 nM dobutamine (at arrow) (N = 3 independent experiments). (C) Epac is required for dob-
mediated PI4P hydrolysis. The Epac inhibitor HJC0726 (1 mM) was added to NRVMs 15 min before imaging and dobutamine (100 nM) was added at the
arrow. (N = 3 independent experiments) (D) Gbg is not required for dobutamine-mediated PI4P hydrolysis. The Gbg inhibitor, Gallein (10 mM) was
added 15 min prior to imaging and dobutamine added as indicated by the arrow (N = 3 independent experiments). Data are not significant between
Dob and Dob + Gallein. Images for A, B,C and D PI4P hydrolysis were taken from at least 4 cells for each separate preparation of NRVMs. (E) Western
blot of Adenoviral sh-RNA knockdown of PLCe. The two bands likely represent two splice variants of PLCe.
DOI: https://doi.org/10.7554/eLife.48167.010
Figure 2 continued on next page
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addition, we sought to determine if receptor internalization is required for NE-mediated PI4P hydro-
lysis and bAR activation at the Golgi. An inhibitor of dynamin-mediated receptor internalization,
Dyngo (40 mM), had no effect on either PI4P hydrolysis (Figure 5D) or recruitment of NES-Venus-
mini-Gs to the Golgi apparatus (Figure 5E and Figure 5—video 1) by NE. As a positive control,
Dyngo does prevent internalization of FLAG-b1AR at the cell surface (Figure 5—figure supplement
1A). Additionally, corticosterone (100 mM) did not alter cAMP production from cell surface bARs
(Figure 5—figure supplement 1B). Corticosterone did not block dobutamine-mediated PI4P hydro-
lysis but rather enhanced the rate of onset relative to dobutamine alone (Figure 5—figure supple-
ment 1C). The reason for this enhancement is unclear but the differential effects of corticosterone
on dobutamine vs NE are consistent with blockade of NE entry into the cell, but not dobutamine.
Together, these data indicate that transport by OCT transporters, not receptor internalization, is
required for NE-mediated Golgi bAR activation and PI4P hydrolysis.
Additionally, NRVMs were transduced with viruses containing FRB-CFP-Nb80 and FKBP-mApple-
GalT, along with FAPP-PH-GFP to determine if Golgi b1AR were required for PI4P hydrolysis to NE.
In cells pretreated with vehicle, NE induces PI4P hydrolysis. However, following addition of 1 mM
Rapamycin, NE-induced PI4P hydrolysis was significantly inhibited (Figure 5F).
To confirm that dobutamine and NE stimulated Golgi PI4P hydrolysis is not unique to neonatal
myocytes we tested the ability of dobutamine and NE to stimulate PI4P hydrolysis in acutely isolated
murine adult ventricular myocytes. Infection of AVMs for 24 hr with FAPP-PH-GFP labels the Golgi
surrounding the nucleus as well as other structures within the myocyte as we have previously
reported (Figure 6A) (Malik et al., 2015). Stimulation of AVMs with dobutamine (Figure 6B) or NE
(Figure 6C) stimulated PI4P depletion in the Golgi. NE-stimulated PI4P hydrolysis was blocked by
preincubation with the Oct3 inhibitor abacavir (Figure 6C) indicating that NE transport into AVMs is
required for stimulation of PI4P hydrolysis, as was seen in NRVMs. These data indicate that internal
receptors are required for stimulation of PI4P hydrolysis in AVMs as well as NRVMs.
Cardiac hypertrophy induced by dobutamine is more effectively
inhibited by a cell permeant antagonist
To determine if signaling by internal bARs is important for promotion of cellular hypertrophy,
NRVMs were treated with dobutamine (100 nM) for 48 hr and two measures of hypertrophy were
assessed, cell area and ANF expression. Dobutamine stimulated an increase cell area (Figure 7A),
and ANF expression (Figure 7B), after 48 hr of stimulation. Co-incubation with the cell permeant
antagonist, metoprolol, strongly inhibited these hypertrophic responses. The cell impermeant antag-
onist, sotalol, on the other hand was significantly less effective at blocking these hypertrophy meas-
ures than metoprolol, (Figure 7A and B). These data, taken together with PI4P hydrolysis data,
suggest that internal bARs are involved in mediating cardiomyocyte hypertrophy.
NE-stimulated NRVM hypertrophy requires membrane transport by
OCT3 and Golgi resident bARs.
NE is an endogenously produced catecholamine involved in mediating hypertrophy and heart failure
and stimulation of NRVMs with NE stimulates hypertrophy. To determine the role of intracellular NE
in hypertrophy, NRVMs were treated with NE in the presence or absence of corticosterone to block
Oct3 cation transporters for 48 hr. Treatment with NE stimulated an increase in cell size (Figure 8A)
and ANF expression (Figure 8B) that was blocked by corticosterone indicating that transport of NE
into the myocyte is required to mediate hypertrophy. Treatment with dobutamine also induced
hypertrophy but this was not blocked by Oct3 supporting the idea that dobutamine access to inter-
nal receptors does not require Oct3 and confirms the specificity of the Oct3 blockade.
To determine if NE and dobutamine driven NRVM hypertrophy requires Golgi bARs NRVMs were
transduced with adenovirus containing CFP-Nb80-FRB and FKBP-mApple-GalT for 24 hr followed by
Figure 2 continued
The following source data is available for figure 2:
Source data 1. Effects of inhibition of PLCe, Epac and Gbg on dobutamine stimulated PI4P hydrolysis.
DOI: https://doi.org/10.7554/eLife.48167.011
Nash et al. eLife 2019;8:e48167. DOI: https://doi.org/10.7554/eLife.48167 7 of 22
Research article Cell Biology
treatment for 48 hr with NE or dobutamine with and without co-treatment with rapamycin. In the
absence of rapamycin, NE and dobutamine stimulated increases in cell area and ANF expression
(Figure 8C and D). Co-treatment with rapamycin to translocate Nb80 to the Golgi blocked NE and
B
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Figure 3. b1ARs in the Golgi are required for PI4P hydrolysis stimulated by dobutamine. NRVMs were transduced with FRB-CFP-Nb80 and FKBP-GalT-
mApple containing adenovirus, along with adenovirus containing FAPP-PH-GFP for 24 hr. (A) Confocal fluorescence images of NRVMs expressing FRB-
CFP-Nb80 in the CFP channel and FKBP-GalT-mApple in the red channel before and after addition of rapamycin (see Materials and methods for
details) Pearson’s correlation coefficient = 0.32 ± 0.03. Scale bars are 10 mm. (B) NRVMs were incubated with either rapamycin (1 mM) or DMSO control
for 15 min prior to addition of dobutamine (100 nM) added at the arrow. Golgi associated FAPP-PH-GFP fluorescence was monitored by time lapse
fluorescence video microscopy as in Figure 1A. (C) Cells were pretreated treated with the cell permeant b1AR selective antagonist, CGP-20712 (100
nM), or vehicle, followed by dobutamine addition and assessed as in B. Images were taken from at least n = 9 cells each from at least four separate
preparations of NRVMs. Data were analyzed as means from N = 4 experiments. Agonists were added as indicated by the arrow.
DOI: https://doi.org/10.7554/eLife.48167.012
The following source data is available for figure 3:
Source data 1. Effects of Golgi targeted NB80 and b1AR-specific antagonism on dobutamine stimulated PI4P hydrolysis.
DOI: https://doi.org/10.7554/eLife.48167.013
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dobutamine stimulated hypertrophy, demonstrating that Golgi bARs are required for stimulation of
hypertrophy by these agonists.
Discussion
We previously found that raising cAMP levels with forskolin in NRVMs stimulated PI4P hydrolysis,
but Iso did not unless a specific PDE, PDE3 was blocked. This led to the question of how the Epac/
mAKAPb/PLCe complex could be activated during physiological cAMP regulation by Gs coupled
receptors. We considered two potential mechanisms, one where chronic agonist exposure alters the
organization of PDEs in the cardiac myocyte such that Epac could be accessed by global cAMP
changes, or that intracellular bARs generate cAMP with privileged access to the Epac/mAKAPb/
PLCe complex. Here we demonstrate that stimulation of Golgi resident b1ARs induces Epac-PLCe-
dependent PI4P hydrolysis when stimulated by either a membrane permeant drug, dobutamine, or
the physiological neurotransmitter, norepinephrine. We also show that stimulation of these internal
receptors is required for both dobutamine and NE stimulated cardiomyocyte hypertrophy.
Compartmentalized GPCR signaling
It is well established that GPCRs can be found on intracellular compartments (Jong et al., 2018). A
number of investigators have characterized GPCRs on the nuclear envelope in neurons and cardiac
myocytes, and signaling mechanisms have been proposed (Kumar et al., 2008; Boivin et al., 2006;
Merlen et al., 2013; Dahl et al., 2018). GPCRs and G proteins have been found on other intracellu-
lar compartments including the Golgi apparatus, but signaling roles for receptors at the Golgi are
not well defined. This is in part because GPCRs are trafficked through the Golgi apparatus on their
way to the cell surface and it has not been clear that GPCRs in the Golgi have a signaling function.
The recent work by Irannejad et al. (2017) definitively demonstrated that Golgi localized b1ARs and
Gs can be driven to an active conformation by exogenous ligands. Recent work from the Calebiro
laboratory demonstrated that the thyroid stimulating hormone (TSH) receptor activates Gs in the
Golgi in mouse thyroid cells through a mechanism that relies on endosomal retrograde trafficking of
internalized receptors (Godbole et al., 2017). This is in contrast to what is shown here in cardiac
myocytes, and as reported by Irannejad et al. in Hela cells, where activation of Golgi b1ARs does not
involve receptor internalization but rather relies on Golgi resident receptors and transport of ligands
across the cell membrane via Oct3.
The work presented here elucidates a possible physiological function for Golgi resident bARs
through a signal transduction pathway we previously demonstrated to be involved in regulation of
cardiac hypertrophy (Figure 9) (Zhang et al., 2011; Zhang et al., 2013; Malik et al., 2015;
Nash et al., 2018). This pathway involves a nuclear envelope scaffolded complex of Epac/PLCe and
mAKAPb. cAMP dependent activation of Epac acts an exchange factor for the small GTPase Rap
which directly stimulates PLCe enzymatic activity toward Golgi PI4P, resulting in local production of
DAG and subsequent nuclear PKD activation. A conundrum arising from previous work was that
direct activation of Epac with a cAMP analog cpTOME, or treatment with forskolin strongly stimu-
lates PLCe dependent Golgi PI4P hydrolysis, however; stimulation with Iso had no effect on PI4P
hydrolysis despite strongly stimulating global cAMP production. Demonstration that a Golgi resident
b1AR can locally activate this system solves this conundrum. Missing from this analysis is demonstra-
tion of the presence of adenylyl cyclase (AC) at the Golgi. Due to the inadequacy of AC antibodies
and the likely low levels of this enzyme, localization of AC by immunocytochemical analysis is not
possible. Nevertheless, binding of AC5 to mAKAPb in cardiac myocytes has been previously demon-
strated (Kapiloff et al., 2009) indicating that AC is likely locally available to be activated by Golgi
b1ARs and Gs.
The purpose of internal GPCR signaling is likely to generate signals that are local and distinct
from receptors at the PM or other intracellular locations. In this way specific processes can be con-
trolled by second messengers that have the potential to activate a vast number of global responses
if the signals were not restricted. In the case of the cardiac myocyte, during acute sympathetic stimu-
lation, norepinephrine may only access cell surface bARs needed to mediate increases in cardiac con-
traction required to meet the demands of a sympathetic response. Because signaling by Golgi bARs
requires uptake of ligand prior to activation, these processes are slower and may not be accessed
during acute sympathetic responses, but rather are only activated during more chronic exposure
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such as is observed in cardiovascular stress. Separation of the Epac/mAKAPb/PLCe pathway at the
nuclear envelope/Golgi interface from global cAMP dependent PKA activation possibly prevents
inappropriate activation of PLCe dependent hypertrophic responses to acute bAR activation.
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Figure 4. The physiological neurotransmitter, norepinephrine, can induce PI4P hydrolysis through internal receptors and can activate bARs at the Golgi.
(A) NRVMs were transduced with FAPP-PH-GFP and stimulated with norepinephrine (10 mM, left) in the presence of metoprolol (100 mM, center) or
sotalol (5 mM, right) and analyzed as in Figure 1A. Data are not significant between norepinephrine and norepinephrine + sotalol. (B) NRVMs were
transfected with b1AR and NES-Venus-mini-Gs, followed by viral transduction with CFP-Giantin. Representative images of norepinephrine-mediated
NES-. Venus-mini-Gs recruitment (10 mM, left columns), CFP-Giantin Golgi marker (B, right). The Pearson’s Coefficient for colocalization of Venus-mini-
Gs and CFP-Giantin is R = 0.455 ± 0.06. Scale bars are 10 mm. All experiments were performed in humidified environmental chamber at 37˚C. Images
for PI4P hydrolysis were collected as in Figure 1A, and were from at least n = 7 cells each from three separate preparations of NRVMs. Data were
analyzed as means from N = 3 experiments. Agonists were added where indicated by the arrow.
DOI: https://doi.org/10.7554/eLife.48167.014
The following video and source data are available for figure 4:
Source data 1. NE stimulates PI4P hydrolysis.
DOI: https://doi.org/10.7554/eLife.48167.015
Figure 4—video 1. Norepinephrine activates b1ARs in the Golgi apparatus.
DOI: https://doi.org/10.7554/eLife.48167.016
Figure 4—video 2. Norepinephrine activates b1ARs in the Golgi apparatus.
DOI: https://doi.org/10.7554/eLife.48167.017
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Figure 5. Norepinephrine requires OCT transporters but not receptor internalization to stimulated PI4P hydrolysis. NRVMs were transduced with FAPP-
PH-GFP and stimulated with norepinephrine (10 mM) in the presence of corticosterone (100 mM, (A), abacavir (10 mM, (B), lamotrigine (10 mM, (C) or
Dyngo (40 mM, (D). Data are not significant between norepinephrine and norepinephrine + Dyngo. Images were collected as in Figure 1A for PI4P
hydrolysis (N = 3) were from at least 4 cells each from separate preparations of NRVMs. Agonists were added where indicated by the arrow. (E) Dyngo
Figure 5 continued on next page
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Requirement for internal b1ARs for cardiac hypertrophy
Significantly, stimulation of hypertrophy by the natural sympathetic ligand NE required activity of
Golgi localized bARs. As has been discussed, sustained elevated sympathetic drive is one of the
major factors responsible for development of cardiac hypertrophy due to chronic hypertension. b-
blocker therapy efficacy is thought to result from preventing chronic stimulation of cell surface bARs
by elevated catecholamines and subsequent desensitization (Bristow, 2000). Our results suggest
that blockade of internal receptors may be required to prevent catecholamine-induced hypertrophy
and demonstrates that activation of cell surface GPCRs is not sufficient for natural catecholamines to
induce hypertrophy in NRVMs. The importance of blockade of Golgi GPCRs is supported by the fact
that the cell permeant bAR antagonist metoprolol is significantly more effective than the cell imper-
meant antagonist sotalol in prevention of dobutamine stimulated cardiomyocyte hypertrophy. Inter-
estingly, clinically effective b-blockers tend to be relatively hydrophobic. Metoprolol and carvedilol
are first line b blockers that are used to treat heart failure and have log P values 1.8 and 4.2 respec-
tively, and are thus relatively cell permeant. Sotalol, which has a log P of  0.85 is relatively cell
impermeant, and is not clinically used for heart failure treatment. We speculate that hydrophobicity
might be an important factor for b-blocker development allowing these inhibitors to access internal
pools of receptor.
A seeming contradiction is the observation that the cell impermeant agonist isoproterenol indu-
ces hypertrophy in vitro and when chronically administered in vivo (Zhang et al., 2011;
Iaccarino et al., 1998). Iso administered in vivo is not at physiological concentrations and has multi-
ple target tissues beyond the cardiac myocyte, such as the vasculature, that could contribute to
hypertrophy. For NRVMs in vitro, while Iso can induce hypertrophy by a mechanism that probably
does not rely on internal receptors, the effects of the natural ligands epinephrine and norepineph-
rine are more relevant to the in vivo situation and do rely on Golgi localized bARs. The synthetic ago-
nist Iso seems to rely on an alternative PM mediated pathway that is not engaged by the
physiological agonist NE. It will be critical to determine if in the in vivo pathology of heart failure
that internal b receptors play a critical role using animal models such as transaortic constriction
(TAC) that mimic hypertensive stress.
Materials and methods
Key resources table
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Strain, strain
background (Rat)
NRVM Freshly isolated
myocytes from
neonatal rats
Continued on next page
Figure 5 continued
has no effect on NES-Venus-mini-Gs Golgi recruitment by norepinephrine. Representative image of norepinephrine-mediated NES-Venus-mini-Gs
recruitment in the presence of Dyngo (40 mM). (N = 3) Scale bars are 10 mm. (F) NRVMs were transduced with adenovirus containing FRB-CFP-Nb80 and
FKBP-GalT-mApple along with adenovirus containing FAPP-PH-GFP for 24 hr prior to experimentation. NRVMs were incubated with either rapamycin (1
mM) or DMSO control for 15 min prior to addition of NE (10 mM) added at the arrow. Images were collected as in Figure 1A for PI4P hydrolysis and
were from at least n = 10 cells each from three separate preparations of NRVMs. Data were analyzed as means from N = 3 experiments.
DOI: https://doi.org/10.7554/eLife.48167.018
The following video, source data, and figure supplement are available for figure 5:
Source data 1. NE requires membrane transport by OCT3 and Golgi resident bARs to stimulate PI4P hydrolysis.
DOI: https://doi.org/10.7554/eLife.48167.020
Figure supplement 1. Receptor internalization does not contribute to Golgi b1AR localization.
DOI: https://doi.org/10.7554/eLife.48167.019
Figure 5—video 1. Inhibition of receptor internalization does not alter activation of b1ARs in the Golgi apparatus.
DOI: https://doi.org/10.7554/eLife.48167.021
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Recombinant
DNA reagent
NES-Venus-mini-Gs Nevin Lambert,
Augusta University,
GA. Wan et al. (2018)
Recombinant
DNA reagent (human)
FLAG-b1 adrenergic
receptor
Addgene RRID:
Addgene_14698
Recombinant
DNA reagent
CFP Giantin Irannejad et al. (2017) Golgi Marker
Adenovirus expressing CFP Giantin MOI 50
Transfected
construct
(Rat)
PLCe-RA1 Zhang et al. (2013) Adenovirus expressing
the RA1 domain from
PLCE1 MOI 50
Transfected
construct
(Rat)
PLCE1-shRNA Zhang et al. (2013) Adenovirus expressing PLCE1 shRNA
MOI 50
Transfected
construct
FAPP-PH-GFP Zhang et al. (2013) Adenovirus expressing
FAPP-PH-GFP
for PI4P detection
MOI 50
Transfected
construct
CFP-Nb80-FRB This paper and
Irannejad et al. (2017)
In this paper
adenovirus was
created for expressing
CFP-Nb80-FRB
previously created
in Irannejad et al. (2017)
MOI 50
Transfected
construct
FKBP-mApple-GalT This paper and Irannejad et al. (2017) In this paper
adenovirus was
created for expressing
FKBP-mApple-GalT
previously created
in Irannejad et al. (2017)
MOI 50
Antibody Anti-b1 adrenergic
receptor
(rabbit polyclonal)
Abcam #ab3442
RRID:
AB_10890808
1:100 dilution
Antibody Anti-TGN38
(sheep anti
Rat polyclonal)
Biorad #AHP499G
RRID:AB_2203272
1:1000 dilution
Antibody M2-FLAG-Cy3
(mouse monoclonal)
Sigma A9594
RRID:AB_439700
5 ug/mL
Chemical
compound, drug
Butanedione
-monoxime (BDM)
Sigma 112135 Myosin blocker
Chemical
compound, drug
Isoproterenol (ISO) Sigma 1351005 bAR agonist
Chemical
compound, drug
Dyngo Abcam Ab120689 Dynamin
inhibitor
Chemical
compound, drug
Sotalol Sigma S0278 bAR antagonist
Chemical
compound, drug
HJC0726 Xiaodong Cheng,
UT Houston Health
Science Center. Zhu et al. (2015)
Epac inhibitor
Chemical
compound, drug
Brefeldin A Biolegend 420601 Golgi disruptor
Chemical
compound, drug
Gallein Sigma 371708 G protein bg
subunit inhibitor
Continued on next page
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Chemical
compound, drug
Corticosterone Tocris 3685 Oct3 inhibitor
Chemical
compound, drug
Metoprolol Sigma M5391 bAR antagonist
Chemical
compound, drug
Dobutamine Tocris 0515 bAR agonist
Chemical
compound, drug
Lamotrigine Tocris 2289 OCT3 blocker
Chemical
compound, drug
Abacavir Tocris 4148 OCT3 blocker
Chemical
compound, drug
Norepinephrine (NE) Sigma A0937 AR agonist
Chemical
compound, drug
Rapamycin (Rapa) Tocris 1292
Peptide,
recombinant
protein
Collagenase Type II Worthington CLS-2
Commercial
assay or kit
cAMP Elisa ENZO ADI-900–066
Isolation of neonatal cardiac myocytes and adenoviral transduction
Briefly, hearts were excised from 2 to 4 day old Sprague-Dawley rats, ventricles separated and
minced thoroughly before digestion with Collagen type II (Worthington) in Hanks buffered saline
solution (HBSS) without Ca2+ or Mg2+. Following digestion, cells were collected by centrifugation
into Dulbecco Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS),
100 U/mL penicillin, 100 mg/mL streptomycin, 2 mM glutamine and 2 mg/mL vitamin B12. Contami-
nating cells were removed by preplating cells onto tissue culture plastic for a minimum of 1 hr at 37˚
C. NRVMs were then plated onto either glass-bottom tissue culture plates or 12 well plates coated
with 0.2% gelatin and cultured in DMEM (composition as above, with additional 10 mM cytosine ara-
binoside). 48 hr later, cells were transferred into media supplemented with 1% FBS. For transduction
with adenovirus, 50 MOI of indicated adenovirus was added overnight upon transfer to 1% FBS con-
taining media. For fluorescent adenovirus constructs, expression was confirmed the next day by epi-
fluorescence microscopy.
Isolation of adult ventricular myocytes
Adult myocytes were isolated from 2 to 4 month-old wild type C57BL/6 mice as previously described
(Auerbach et al., 2013). Briefly, mice were anesthetized with ketamine (100 mg/kg body weight)
and xylazine (5 mg/kg body weight) i.p.. Hearts were cannulated and perfused with perfusion buffer
via the aorta. Subsequently, the hearts were perfused with digestion buffer consisting of: collage-
nase type-II (773.48 U/mL), trypsin (0.14 mg/mL), and calcium chloride (12.5 mM) in the perfusion
buffer (pH 7.46). The atria were removed and the ventricles were minced in stop buffer containing
10% FBS and 12.5 mM calcium chloride in perfusion buffer. After calcium was added back to a final
concentration of 1 mM, cells were plated onto laminin-coated 20 mm glass bottom dishes in mini-
mum essential medium supplemented with 0.35 g/L sodium bicarbonate, 2.5% FBS, and 10 mM 2,3
butanedione monoxime (BDM).
Transduction of AVMs with adenovirus
After AVMs were adhered to the laminin-coated 20 mm dishes for 1 hr, plating media was removed
and cells were transduced with adenoviruses expressing FAPP-PH-GFP (100 MOI) in BDM-free media
for 2–3 hr. The virus was then removed and BDM was added to the culture media. 18–24 hr later,
cells were imaged by confocal microscopy with a 40X oil-immersion lens for measurement of FAPP-
PH-GFP fluorescence. EGFP was excited at 488 nm and images were acquired with 25 ms exposures
at 2.5 min intervals.
Nash et al. eLife 2019;8:e48167. DOI: https://doi.org/10.7554/eLife.48167 14 of 22
Research article Cell Biology
NES-Venus-mini-Gs imaging
NRVMs were plated into gelatin-coated 20 mm glass bottom cell culture dishes. Cells were trans-
fected the following day with plasmids (500–800 ng of b1-ARs and 250–400 ng of NES-Venus-mini-
Gs per dish) using lipofectamine 3000. Media was changed to 1% FBS the next day and transduced
with adenovirus-expressing CFP- Giantin overnight. Cells were imaged in confocal mode with a Leica
DMi8 equipped with a Crest-optics X-light V2 confocal unit and a 100  1.4 NA oil-immersion lens.
Venus was excited at 515 with an X-Cite Xled1 light source, and emission monitored imaged on a
backlit CMOS Photometrics Prime 95B camera.
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Figure 6. Dobutamine and NE stimulate PI4P hydrolysis in Adult Ventricular Myocytes (AVMs). Freshly isolated
mouse AVMs were infected with FAPP-PH-GFP (100 MOI) for 24 hr. (A) representative image of an AVM expressing
FAPP-PH-GFP showing strong labeling surrounding the nucleus. (B) FAPP-PH-GFP expressing AVMs were treated
with either dob or PBS control as indicated and were imaged as for NRVMs as in Figure 1A for PI4P hydrolysis.
Fluorescence intensity in the region surrounding the nucleus was quantitated at 5 min intervals. C) AVMs were
treated with PBS control, NE (10 mM) or NE plus abacavir and analyzed as in B. Data for B and C are from at least
n = 3 cells each from three separate preparations of AVMs. Data were analyzed as means from N = 3 experiments.
DOI: https://doi.org/10.7554/eLife.48167.022
The following source data is available for figure 6:
Source data 1. NE-Stimulated PI4P hydrolysis in adult cardiac myocytes requires OCT3.
DOI: https://doi.org/10.7554/eLife.48167.023
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Figure 7. Dobutamine induced cardiomyocyte hypertrophy requires intracellular bARs. (A) Dobutamine induces internal-receptor dependent increases
in cell area. NRVMs were transduced with YFP virus prior to stimulation for 48 hr with dobutamine in the presence of the indicated antagonists or
vehicle control. Following fixation, cell area was measured using image J. Representative images are on the left with mean data (fold over basal, FOB)
on the right (N = 4 separate preparations of NRVMs), analyzed with a paired two way ANOVA. ****p<0.0001 vs. Dob and Dob+sotalol. Scale bars are
10 mm. B) Dobutamine induces an increase in ANF expression via an internal receptor-dependent mechanism. NRVMs were stimulated with
dobutamine in the presence or absence of the indicated antagonists or vehicle control for 48 hr before fixation and staining for ANF. Fluorescence of
ANF rings was then captured by confocal microscopy, followed by fluorescence intensity analysis with Image J. Representative images are on the left
with mean data (fold over basal, FOB) on the right (N = 3 separate preparations of NRVMs), analyzed with a paired two way ANOVA. **p=0.007 vs. Dob
and Dob+sotalol. The total number of cells analyzed was greater than 200 cells for each.
DOI: https://doi.org/10.7554/eLife.48167.024
Figure 7 continued on next page
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Measurement of PI4P hydrolysis
Measurements of PI4P hydrolysis were made as previously described (Zhang et al., 2013;
Malik et al., 2015; Nash et al., 2018). After preparation and culture of myocytes, cells were trans-
duced with adenovirus (50 MOI) expressing GFP-FAPP-PH overnight. The following day, expression
was confirmed by epifluorescence microscopy. Time lapse video fluorescence Imaging of GFP-FAPP-
PH fluorescence was performed at room temperature or 37˚C, where indicated, on a LEICA DMi8
with a 20x air lens in confocal mode. EGFP was excited at 488 nm with an X-Cite Xled1 light source
and emission monitored imaged on a backlit CMOS Photometrics Prime 95B camera. Images were
acquired with 50 ms exposure times at 1 min intervals to minimize photobleaching. Analysis of fluo-
rescence intensity changes from the videos was performed using NIH Image J unless otherwise
stated. Analysis was performed by subtracting background fluorescence intensity from a region of
interest intensity at all time points measured. Data is presented as percentage of fluorescence
remaining after agonist stimulation when compared to cells prior to stimulation.
Measurement of myocyte cell area
NRVMs were plated into gelatin-coated 12 well plates or glass-bottom 96 well plates and allowed to
grow overnight. The following day, cells were infected overnight with adenovirus expressing YFP.
Subsequently, NRVMs were stimulated with dobutamine (100 nM) or norepinephrine (10 mM) for 48
hr, in the presence of antagonists or transduction with FRB-CFP-Nb80 and FKBP-mApple-GalT, as
indicated. Following stimulation, cells were fixed in 4% (w/v) paraformaldehyde. Fluorescent images
were taken at 10 x magnification and cell area measured using NIH Image J or Cell Profiler software
from over 500 cells from at least three separate experiments.
Immunocytochemistry for ANF induction
NRVMs were plated into gelatin-coated eight chamber glass slides or glass-bottom 96 well plates
and allowed to grow overnight. The following day, cells were serum starved for 24 hr. Subsequently,
NRVMs were stimulated with dobutamine (100 nM) or norepinephrine (10 mM) for 48 hr, in the pres-
ence of antagonists or transduction with FRB-CFP-Nb80 and FKBP-mApple-GalT, as indicated. Cells
were washed with PBS and fixed with 4% PFA for 15 min and then incubated with 10% normal goat
serum in phosphate buffered saline containing 0.1% Triton X100 (PBS-T) for 1 hr at room tempera-
ture. Primary antibody was incubated at a dilution of 1:1000 in 2% goat serum in PBS-T overnight at
4C. After three washes with PBS-T, cells were incubated with secondary antibody (Goat anti-rabbit
Alexa Fluor 568) at a dilution of 1:1000 in PBS-T for 1.5 hr at room temperature. After three washes
with PBS-T, DAPI was added at a dilution of 1:500 in PBS and incubated for 30 min. Fluorescence
images were captured at 10 x magnification and fluorescence intensity corresponding to ANF stain-
ing surrounding the nucleus was quantified using either NIH Image J or Cell Profiler software.
Inhibition of Golgi bARs by Nb80
NRVMs were plated onto 20 mm glass bottom coverslips and allowed to adhere for 24 hr. Following
adhesion, cells were transduced with adenoviruses containing FKBP-mApple-GalT construct and
FRB-CFP-Nb80. The following day, NRVMs were transduced with adenovirus (50 MOI) expressing
GFP-FAPP-PH overnight. 15 min prior to experimentation, cells were treated with either 1 mM rapa-
mycin or DMSO, where indicated, to induce translocation of Nb80 to the Golgi membrane. Imaging
of GFP-FAPP-PH fluorescence was performed at 37˚C on a LEICA DMi8 in confocal mode with a 20 x
air lens. Analysis was performed as for PI4P hydrolysis as previously indicated.
Saponin permeabilization and visualization of Nb80 translocation
NRVMs were plated onto 20 mm glass bottom coverslips and allowed to adhere for 24 hr. Following
adhesion, cells were transduced with adenoviruses containing FKBP-mApple-GalT construct and
Figure 7 continued
The following source data is available for figure 7:
Source data 1. Dobutamine-stimulated cardiomyocyte hypertrophy is blocked by a cell permeable bAR antagonist.
DOI: https://doi.org/10.7554/eLife.48167.025
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Figure 8. Dobutamine and norepinephrine induced cardiomyocyte hypertrophy requires Golgi-localized bARs. Norepinephrine induced hypertrophy
also requires agonist internalization. Norepinephrine induces internal-receptor dependent increases in cell area (A) and ANF expression (B). NRVMs
were stimulated for 48 hr with norepinephrine (10 mM) or dobutamine (100 nM) in the presence of Corticosterone (100 mM) or vehicle control. Following
fixation, cells were stained for ANF and using CellTracker Deep Red. Images were captured using a Thermo Fisher Cell Insight and analyzed by Cell
Profiler. Both NE and Dobutamine significantly increase cell size (NE, p<0.05 and Dob p<0.001) and ANF expression (NE, p<0.01 and Dob p<0.001) in
control conditions. Dobutamine and Norepinephrine require Golgi localized bAR to induce increase in cell area (C) and ANF expression (D). NRVMs
were transduced with FRB-CFP-Nb80 and FKBP-mApple-GalT for 24 hr before stimulation. 15 min before agonist addition, Rapamycin or (1 mM) or
vehicle control was added. Cells were then stimulated with either dobutamine (100 nM) or norepinephrine (10 mM) for 48 hr. Following fixation, cells
were stained for ANF and using CellTracker Deep Red. Images were captured using a Thermo Fisher Cell Insight and analyzed by Cell Profiler. Both NE
Figure 8 continued on next page
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FRB-CFP-Nb80. After 48 hr of transduction, cells were treated with either 1 mM rapamycin or PBS
control for 15 min. Following treatment, cells were permeabilized with PEM/saponin buffer (80 mM
K-PIPES, pH 6.8, 5 mM EGTA, 1 mM MgCl2, 0.05% saponin) for 5 min on ice. Subsequently, cells
were fixed with 4% formaldehyde and imaged on a LEICA DMi8 microscope in confocal mode with a
20 x air lens.
Figure 8 continued
and dobutamine significantly increase cell size (NE, p<0.001 and Dob p<0.01) and ANF expression (NE, p<0.001 and Dob p<0.001) in control
conditions. All data is from at least 1200 cells from three separate preparations of NRVMs. Data were analyzed as means from N = 3-4 experiments.
DOI: https://doi.org/10.7554/eLife.48167.026
The following source data is available for figure 8:
Source data 1. NE-stimulated hypertrophy requires OCT3 and Golgi resident bARs.
DOI: https://doi.org/10.7554/eLife.48167.027
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Figure 9. Signal transduction by cell surface and Golgi b1ARs. b1ARs are located on both the plasma membrane
and the Golgi apparatus in cardiac myocytes. Stimulation of cell surface b1ARs leads to production of cytosolic
cAMP but this cAMP cannot access the Epac/PLCe/mAKAPb due to PDE3 dependent hydrolysis of cAMP. To
access Golgi b1AR, NE crosses the plasma membrane via the Oct3 transporter. We speculate that the Oct3
transporter is also present in the Golgi allowing access to the Golgi lumen and there is evidence for the presence
of Oct3 on intracellular membranes as discussed in the text. Once activated in the Golgi, b1AR stimulates Gs and
subsequent production of cAMP locally. Missing from this diagram is adenylyl cyclase which we presume is in the
Golgi apparatus. There is evidence for adenylyl cyclase binding to mAKAPb in cardiac myocytes. Local cAMP has
privileged access to the Epac/PLCe/mAKAPb complex which leads to PLCe-dependent production of local DAG
from PI4P.
DOI: https://doi.org/10.7554/eLife.48167.028
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Internalization of b1-adrenergic receptor
NRVMs were plated onto 20 mm glass bottom coverslips and allowed to adhere for 24 hr. Following
adhesion, cells were transfected with 500 ng of FLAG-b1-AR and allowed to express for 48 hr. The
day of the experiment, cells were incubated with 5 mg/ml of M2-FLAG-Cy3 antibody for 1 hr at 37˚C.
Subsequently, cells were stimulated with agonists as indicated for 30 mins, in the presence or
absence of 40 mM Dyngo. Cells were then washed twice with ice-cold HBSS before fixation in 4%
formaldehyde. Cells were imaged on a LEICA DMi8 microscope in confocal mode with 63x oil lens.
cAMP ELISA
NRVMs were plated onto 96 well plates and grown for a minimum of two days before stimulation.
Cells were washed twice with HBSS (+Ca2+/Mg2+) and incubated with IBMX (300 mM) for 10 mins
before addition of inhibitors for a further 10 mins, as indicated. Agonist stimulations were performed
in HBSS buffer for 10 min before termination of assay with 0.1 M HCl. cAMP assay was performed
according to kit instructions (Direct cAMP ELISA, Enzo Life Sciences).
Statistical Analysis: All graphs are presented as the mean ±SE of the results from independent
preparations of cells (ie. N = 3–4 as indicated in the figure legends). Agonist treatments were com-
pared to vehicle control performed on the same day and were added where indicated by the arrow.
All data was analyzed by two-way unpaired ANOVA with Sidak’s post-hoc test unless otherwise indi-
cated. *p<0.05 **p<0.001 ***p<0.0001 ****p<0.00001 using GraphPad Prism 7.0.
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